Early Access

10-KPeriod: FY2023

Cigna Group Annual Report, Year Ended Dec 31, 2023

Filed February 29, 2024For Securities:CI

Summary

The Cigna Group (CI) reported robust financial performance in its 2023 10-K filing, demonstrating growth across its key segments. The company's Evernorth Health Services segment showed significant revenue expansion, driven by strong performance in its pharmacy benefit services and specialty offerings. Cigna Healthcare also experienced revenue growth, largely due to an increase in medical customers and favorable premium rate adjustments. The company highlighted its strategic focus on innovation and digital capabilities to enhance customer experience and control costs. Significant strategic moves were announced, including the definitive agreement to sell its Medicare Advantage and related businesses to Health Care Service Corporation (HCSC) for $3.3 billion. This divestiture is expected to reshape the company's portfolio, allowing for a greater focus on its core Evernorth Health Services and evolving Cigna Healthcare offerings. The company also continued its commitment to returning capital to shareholders through share repurchases and dividends, signaling financial strength and confidence in its future prospects.

Financial Statements
Beta

Key Highlights

  • 1Evernorth Health Services delivered strong revenue growth of 9%, reaching $153.5 billion, indicating sustained demand for its pharmacy, specialty, and care solutions.
  • 2Cigna Healthcare saw a significant 14% increase in adjusted revenue to $51.2 billion, supported by customer growth and favorable premium rate adjustments.
  • 3The company announced the sale of its Medicare Advantage and related businesses to HCSC for $3.3 billion, a strategic move to streamline its portfolio.
  • 4Adjusted income from operations grew 2% to $7.45 billion, demonstrating the company's ability to manage profitability alongside growth.
  • 5The company repurchased approximately $2.3 billion of its common stock in 2023, underscoring its commitment to shareholder returns.
  • 6Capital expenditures for technology investments increased to $1.6 billion, reflecting a strategic focus on digital capabilities and innovation.
  • 7The company ended the year with strong liquidity, reporting $7.8 billion in cash and cash equivalents.

Frequently Asked Questions